XENON PHARMACEUTICALS INC. Shares Outstanding (Cover Page)
XENON PHARMACEUTICALS INC. (XENE) had Shares Outstanding (Cover Page) of 96.84 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 96.84M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 96.67M shares.
- 2026-02-23: Entity Common Stock, Shares Outstanding 83.19M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 77.28M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 96.84M shares 10-Q · filed 2026-08-06 |
| 2026-05-04 | 96.67M shares 10-Q · filed 2026-05-07 |
| 2026-02-23 | 83.19M shares 10-K · filed 2026-02-26 |
| 2025-10-30 | 77.28M shares 10-Q · filed 2025-11-03 |
| 2025-08-07 | 77.11M shares 10-Q · filed 2025-08-11 |
| 2025-05-08 | 76.73M shares 10-Q · filed 2025-05-12 |
| 2025-02-24 | 76.54M shares 10-K · filed 2025-02-27 |
| 2024-11-08 | 76.24M shares 10-Q · filed 2024-11-12 |
| 2024-08-05 | 75.76M shares 10-Q · filed 2024-08-08 |
| 2024-05-06 | 75.47M shares 10-Q · filed 2024-05-09 |
| 2024-02-26 | 75.43M shares 10-K · filed 2024-02-29 |
| 2023-11-03 | 65.43M shares 10-Q · filed 2023-11-08 |
| 2023-08-04 | 64.15M shares 10-Q · filed 2023-08-09 |
| 2023-05-05 | 63.56M shares 10-Q · filed 2023-05-09 |
| 2023-02-24 | 63.04M shares 10-K · filed 2023-03-01 |
| 2022-11-04 | 62.54M shares 10-Q · filed 2022-11-08 |
| 2022-08-05 | 62.26M shares 10-Q · filed 2022-08-09 |
| 2022-05-06 | 53.11M shares 10-Q · filed 2022-05-10 |
| 2022-02-25 | 51.92M shares 10-K · filed 2022-03-01 |
| 2021-11-08 | 51.59M shares 10-Q · filed 2021-11-10 |
| 2021-08-09 | 41.12M shares 10-Q · filed 2021-08-11 |
| 2021-05-07 | 40.97M shares 10-Q · filed 2021-05-11 |
| 2021-02-26 | 35.81M shares 10-K · filed 2021-03-01 |
| 2020-11-03 | 35.01M shares 10-Q · filed 2020-11-05 |
| 2020-08-04 | 34.99M shares 10-Q · filed 2020-08-06 |
| 2020-05-18 | 34.97M shares 10-Q/A · filed 2020-05-26 |
| 2020-03-05 | 34.96M shares 10-K · filed 2020-03-09 |
| 2019-11-01 | 25.87M shares 10-Q · filed 2019-11-05 |
| 2019-08-02 | 25.78M shares 10-Q · filed 2019-08-06 |
| 2019-05-03 | 25.77M shares 10-Q · filed 2019-05-07 |
| 2019-03-01 | 25.75M shares 10-K · filed 2019-03-06 |
| 2018-11-02 | 25.24M shares 10-Q · filed 2018-11-06 |
| 2018-08-03 | 19.26M shares 10-Q · filed 2018-08-07 |
| 2018-05-04 | 14.17M shares 10-Q · filed 2018-05-08 |
| 2018-03-02 | 18.00M shares 10-K · filed 2018-03-07 |
| 2017-11-03 | 18.00M shares 10-Q · filed 2017-11-07 |
| 2017-07-31 | 18.00M shares 10-Q · filed 2017-08-03 |
| 2017-05-05 | 18.00M shares 10-Q · filed 2017-05-09 |
| 2017-03-03 | 17.94M shares 10-K · filed 2017-03-08 |
| 2016-10-28 | 17.89M shares 10-Q · filed 2016-11-03 |
| 2016-07-29 | 14.43M shares 10-Q · filed 2016-08-03 |
| 2016-05-06 | 14.40M shares 10-Q · filed 2016-05-10 |
| 2016-03-04 | 14.40M shares 10-K · filed 2016-03-08 |
| 2015-11-02 | 14.38M shares 10-Q · filed 2015-11-10 |
| 2015-08-07 | 14.29M shares 10-Q/A · filed 2015-08-13 |
| 2015-05-11 | 14.23M shares 10-Q · filed 2015-05-12 |
| 2015-03-09 | 14.22M shares 10-K · filed 2015-03-12 |
| 2014-11-30 | 14.18M shares 10-Q · filed 2014-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |